Jason A. Rosenzweig to Mice
This is a "connection" page, showing publications Jason A. Rosenzweig has written about Mice.
Connection Strength
0.332
-
Lawal A, Kirtley ML, van Lier CJ, Erova TE, Kozlova EV, Sha J, Chopra AK, Rosenzweig JA. The effects of modeled microgravity on growth kinetics, antibiotic susceptibility, cold growth, and the virulence potential of a Yersinia pestis ymoA-deficient mutant and its isogenic parental strain. Astrobiology. 2013 Sep; 13(9):821-32.
Score: 0.055
-
Rosenzweig JA, Jejelowo O, Sha J, Erova TE, Brackman SM, Kirtley ML, van Lier CJ, Chopra AK. Progress on plague vaccine development. Appl Microbiol Biotechnol. 2011 Jul; 91(2):265-86.
Score: 0.047
-
Lawal A, Jejelowo OA, Rosenzweig JA. The effects of low-shear mechanical stress on Yersinia pestis virulence. Astrobiology. 2010 Nov; 10(9):881-8.
Score: 0.045
-
Rosenzweig JA, Chromy B, Echeverry A, Yang J, Adkins B, Plano GV, McCutchen-Maloney S, Schesser K. Polynucleotide phosphorylase independently controls virulence factor expression levels and export in Yersinia spp. FEMS Microbiol Lett. 2007 May; 270(2):255-64.
Score: 0.035
-
Rosenzweig JA, Schesser K. Polynucleotide phosphorylase and the T3SS. Adv Exp Med Biol. 2007; 603:217-24.
Score: 0.035
-
Rosenzweig JA, Weltman G, Plano GV, Schesser K. Modulation of yersinia type three secretion system by the S1 domain of polynucleotide phosphorylase. J Biol Chem. 2005 Jan 07; 280(1):156-63.
Score: 0.030
-
Andersson JA, Fitts EC, Kirtley ML, Ponnusamy D, Peniche AG, Dann SM, Motin VL, Chauhan S, Rosenzweig JA, Sha J, Chopra AK. New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrob Agents Chemother. 2016 06; 60(6):3717-29.
Score: 0.017
-
Sha J, Rosenzweig JA, Kozlova EV, Wang S, Erova TE, Kirtley ML, van Lier CJ, Chopra AK. Evaluation of the roles played by Hcp and VgrG type 6 secretion system effectors in Aeromonas hydrophila SSU pathogenesis. Microbiology (Reading). 2013 Jun; 159(Pt 6):1120-1135.
Score: 0.013
-
Sha J, Kirtley ML, van Lier CJ, Wang S, Erova TE, Kozlova EV, Cao A, Cong Y, Fitts EC, Rosenzweig JA, Chopra AK. Deletion of the Braun lipoprotein-encoding gene and altering the function of lipopolysaccharide attenuate the plague bacterium. Infect Immun. 2013 Mar; 81(3):815-28.
Score: 0.013
-
Erova TE, Rosenzweig JA, Sha J, Suarez G, Sierra JC, Kirtley ML, van Lier CJ, Telepnev MV, Motin VL, Chopra AK. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine. Clin Vaccine Immunol. 2013 Feb; 20(2):227-38.
Score: 0.013
-
Sha J, Rosenzweig JA, Kirtley ML, van Lier CJ, Fitts EC, Kozlova EV, Erova TE, Tiner BL, Chopra AK. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague. Microb Pathog. 2013 Feb; 55:39-50.
Score: 0.013
-
Wiley DJ, Nordfeldth R, Rosenzweig J, DaFonseca CJ, Gustin R, Wolf-Watz H, Schesser K. The Ser/Thr kinase activity of the Yersinia protein kinase A (YpkA) is necessary for full virulence in the mouse, mollifying phagocytes, and disrupting the eukaryotic cytoskeleton. Microb Pathog. 2006 May; 40(5):234-43.
Score: 0.008
-
Edgeworth RL, San JH, Rosenzweig JA, Nguyen NL, Boyer JD, Ugen KE. Vaccine development against HIV-1: current perspectives and future directions. Immunol Res. 2002; 25(1):53-74.
Score: 0.006